CORBUS PHARMACEUTICALS HLDGS (CRBP): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in CRBP · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
7
13F filers
Aggregate Value
$19.3M
Across holders
Last Price
$4.46
2026-10-19
Sector
Health Care
GICS
Quarterly fund activity0 increased5 reduced5 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC CIK 0001055951 | Hedge Fund | 1.74M | $16.3M | 84.6% | 0.3% | Unchanged | +$0 | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 111K | $1.0M | 5.4% | 0.0% | Reduced | $-2.2M | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 92K | $864K | 4.5% | 0.0% | Reduced | +$756K | Q2 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 79K | $744K | 3.9% | 0.0% | Reduced | $-1.9M | Q2 2026 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 22K | $211K | 1.1% | 0.0% | Reduced | $-96K | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 11K | $107K | 0.6% | 0.0% | Reduced | $-904K | Q2 2026 |
| Ancora Advisors, LLC CIK 0001446114 | Hedge Fund | 64 | $600 | 0.0% | 0.0% | Unchanged | +$0 | Q2 2026 |
Unchanged
Hedge Fund
$16.3M· 84.6% of total· 0.3% port· 1.74M sh· +$0 QoQ· Q2 2026
Reduced
Hedge Fund
$1.0M· 5.4% of total· 0.0% port· 111K sh· $-2.2M QoQ· Q2 2026
Reduced
Hedge Fund
$864K· 4.5% of total· 0.0% port· 92K sh· +$756K QoQ· Q2 2026
Reduced
Hedge Fund
$744K· 3.9% of total· 0.0% port· 79K sh· $-1.9M QoQ· Q2 2026
Reduced
Hedge Fund
$211K· 1.1% of total· 0.0% port· 22K sh· $-96K QoQ· Q2 2026
Reduced
Hedge Fund
$107K· 0.6% of total· 0.0% port· 11K sh· $-904K QoQ· Q2 2026
Unchanged
Hedge Fund
$600· 0.0% of total· 0.0% port· 64 sh· +$0 QoQ· Q2 2026
Recent insider activity
Form 4 purchases and sales · 24 Jul 2026 – 21 Oct 20261 buyers · $25K2 sellers · $292K3 transactions
| Insider ⇅ | Trades ⇅ | Bought ⇅ | Sold ⇅ | Largest ⇅ | Latest ▼ | |
|---|---|---|---|---|---|---|
| Saxena Nishant C Chief Business Officer | 1 1 buy · 0 sell | $25K | — | $25K | 11 Aug 2026SEC ↗ | |
| Cohen Yuval Chief Executive Officer | 1 0 buy · 1 sell | — | $171K | $171K | 7 Aug 2026SEC ↗ | |
| Moran Sean F. Chief Financial Officer | 1 0 buy · 1 sell | — | $121K | $121K | 7 Aug 2026SEC ↗ |
Distinct buyers and sellers may overlap. “Largest” is the largest reported transaction value in this window. Expand a row to see up to five recent filings.